Skip to main content
NL
FR
EN
Other information and services:
www.belgium.be
Your medicine and health products
About the FAMHP
Jobs
Publications
Press
Contact
Complaints
Webportal
Search
Home
Human use
Veterinary use
Information for the public
Information for professionals
Home
Human use
Medicines
Current Page:
Medicines
Medicines
COVID-19
Research and development
Vaccines
Scientific-technical advice
Introduction
Procedures
Regulation
Fees
FAQ's
Statistics
National Innovation Office
Meeting with FAMHP experts
Innovation activities
Specific support to SMEs and academics
Presentations, workshops & events
Contact
Research & Development
Clinical trials
Fees
Vigilance
Ethic committee
compassionate use - medical need
Marketing Authorisation procedures
Procedures
Procedures after the first marketing autorisation
Falsified Medicines Directive 2011/62/EU
CTD
eSubmission
Risk management plan and risk management activities
Other procedures
Pharmacovigilance
Reglementation
Notification
Data collection, evaluation and measures
VIG-NEWS
DHPC's - Direct Healtcare Professional Communications
Info ICSRs - MAH & sponsors
Inspections - QPPV
Questions and answers regarding reporting adverse reactions
Production
Good Manufacturing Practice
New legislation for qualified persons
Qualified person
FAQ's
Distribution & Delivery
Good Distribution Practices
Brokers
Marketing/ Unavailability
Sunset clause
Full-line wholesalers
Pharmacy for the public
Hospital pharmacy
Therapeutic Magistral Form
INN prescription
Responsible for information
Advertising-premiums-advantages-samples
Autorisations - certificates
Authorisation RD 14/12/2006
Regulation (EU) No 536/2014
Request for certificates, seen and certified copy
Templates certificates
Prices of Certificates
Declarations - Registrations
Medicines for export
API - fabrication - importation - distribution
Proper use of medicines
12 tips for proper use of medicines
Antibiotics
Expired or unused medicines
Questions and answers on seizure of postal packages
Information about medicines
Authorised medicines in Belgium
Online patient information leaflets
(Un)availability of medicines
Medicinal products database
PharmaStatus
BCFI/CBIP
Authentic Source of Medicines (SAM)
Additional risk minimisation activities (RMA)
Last updated on 10/02/2023
For full functionality of this site it is necessary to enable JavaScript.
Here are the
instructions how to enable JavaScript in your web browser
.